Site Search

Earlier this morning, House Bill 1754 was voted out of the Senate Banking & Insurance Committee. This legislation, which aims to ensure that biomarker testing is covered by Medicaid and all other state-regulated insurance plans when patients need it, now advances to the Senate floor for consideration. Biomarker testing is a precision medicine tool that utilizes information from patients’ disease cells to determine the right treatment at the ...

This afternoon, the Pennsylvania State House passed legislation that would ensure biomarker testing is covered by more insurance plans, including Medicaid, when patients need it. Biomarker testing has revolutionized cancer treatment over the last few decades and is increasingly important in the treatment of other conditions, ...

... leaders at the state Capitol and urged their colleagues in the House and Senate to support legislation improving Pennsylvanians’ access to biomarker testing. Biomarker testing has become a game-changing part of patient care given its role in opening the door to targeted treatments that can lead to ...

Earlier today, the Pennsylvania State Senate unanimously passed House Bill 1754, the bipartisan proposal to increase access to biomarker testing. The bill will now go to Governor Shapiro’s desk, providing him the opportunity to ensure coverage of this essential testing for more Pennsylvanians. The American Cancer Society Cancer Action Network (ACS CAN) and the PA Biomarker Testing Coalition are advocating for this significant policy change to ensure more cancer patients and people with other illnesses and ...